Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol

Chad Moretz1, Lindsay GS Bengtson2, Lucie Sharpsten2, Eleena Koep2, Lisa Le2, Junliang Tong2, Richard H Stanford1, Beth Hahn1, Riju Ray1 1Glaxo Smith Kline, Research Triangle Park, Durham, NC, USA; 2Optum, Eden Prairie, MN, USACorrespondence: Chad MoretzGlaxoSmithKline, Research Triangle Park, 5 Moo...

Full description

Bibliographic Details
Main Authors: Moretz C, Bengtson LGS, Sharpsten L, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:International Journal of COPD
Subjects:
COPD
long-acting β2-agonists
long-acting muscarinic antagonists
adherence
rescue medication
real world
Online Access:https://www.dovepress.com/evaluation-of-rescue-medication-use-and-medication-adherence-receiving-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/evaluation-of-rescue-medication-use-and-medication-adherence-receiving-peer-reviewed-article-COPD

Similar Items